Shravan Madireddi
Genentech · 40 works · 2,504 citations · h-index 17
Top works
- Peripheral T cell expansion predicts tumour infiltration and clinical response
- High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
- TNF superfamily in inflammatory disease: translating basic insights
- CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy
- Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
- Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
- Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
- 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
- High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
- Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1
- A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
- SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ
- Regulatory T Cell–Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9
- Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members
- Cutting Edge: 4-1BB Controls Regulatory Activity in Dendritic Cells through Promoting Optimal Expression of Retinal Dehydrogenase
- SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model
- In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales
- Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
- ProtEx™ technology for the generation of novel therapeutic cancer vaccines
- Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+T Cells into CD4+FoxP3+T Regulatory Cells by Production of IFN-γ